Fundz

Pathalys Pharma Appoints Bastian Dehmel, M.D. as Chief Medical Officer

PRIVATEAug 13, 2024

Position

Chief Medical Officer

Company

Pathalys Pharma

Bastian Dehmel
bdehmel@pathalys.com
RaleighBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Pathalys Pharma, Inc. has appointed Bastian Dehmel, M.D. as its Chief Medical Officer

Quick answer

Pathalys Pharma Appoints Bastian Dehmel, M.D. as Chief Medical Officer (August 13, 2024). Pathalys Pharma is based in Raleigh, North Carolina, United States.

Who is the new Chief Medical Officer at Pathalys Pharma?
Pathalys Pharma named Bastian Dehmel Chief Medical Officer, announced August 13, 2024.
What did Pathalys Pharma announce on August 13, 2024?
Pathalys Pharma, Inc. has appointed Bastian Dehmel, M.D. as its Chief Medical Officer
What does Pathalys Pharma do?
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of ESKD.
Where is Pathalys Pharma based?
Pathalys Pharma is based in Raleigh, North Carolina, United States.
Which similar companies made leadership changes around the same time?
Pfizer (August 13, 2024), Fulcrum Therapeutics (August 19, 2024), Belite Bio (September 1, 2024) and Forward Therapeutics (September 3, 2024) also announced leadership changes within 45 days of Pathalys Pharma.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Pathalys Pharma, and when

A new leader at Pathalys Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Pathalys Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pathalys Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pathalys Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pathalys Pharma

Location

Raleigh, North Carolina, United States

About

Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of ESKD. Pathalys' initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pathalys Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bastian
Likely contact at this company
••••••••@••••••••

See Bastian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Pathalys Pharma's next move

Learn about Strategic plan

Pathalys Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.